|Bid||222.03 x 800|
|Ask||221.98 x 800|
|Day's Range||221.01 - 223.34|
|52 Week Range||208.07 - 287.94|
|Beta (3Y Monthly)||0.70|
|PE Ratio (TTM)||16.67|
|Earnings Date||Oct 15, 2019|
|Forward Dividend & Yield||4.32 (1.95%)|
|1y Target Est||287.75|
Health care companies need to learn how to communicate. Startups need to be better listeners. And everyone has something to learn from the financial industry. These were some of the key takeaways from a "reverse pitch" panel featuring John Santelli, the CIO of UnitedHealth Group and Cris Ross, CIO of Mayo Clinic.
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
The coming week’s docket of economic reports and earnings releases comes just following the Trump administration’s announcement of a partial trade deal with China late last week.
One of Houston's largest hospital systems and the nation's largest health insurance provider are at odds over the costs of health care.
With most blue-chip companies earnings scheduled over the coming weeks and sentiments being mixed, investors should closely monitor the movement of the Dow ETF and grab an opportunity that arises from a surge in any of the 30 stocks.
Down about 3% this year, the iShares U.S. Healthcare Providers ETF (IHF) is a laggard among healthcare ETFs and that's saying something because the sector is one of the worst performers in the S&P 500. IHF is a traditional index fund that targets U.S. equities in the healthcare providers sector. Many of the most visible Democratic contenders for that party’s 2020 presidential nomination are embracing Medicare For All.
When it comes to trade deals, size may matter, but smaller is also better than nothing at all. Delegates from China and Trump Administration officials started two days of trade meetings today in Washington and it looks like a "mini deal" is what's on the table.Source: Venturelli Luca / Shutterstock.com Although President Trump has long rebuked the idea of a small trade deal with China, that may be what ultimately comes of the two-day meeting and stocks seem to like the idea. Trump posted on Twitter earlier today that he plans to meet with Vice Premier Liu He tomorrow."The White House is looking at rolling out a previously agreed currency pact with China as part of an preliminary deal that could also see a planned tariff increase next week suspended," reports Bloomberg. "Separately, Bloomberg is reporting that China plans to ask the U.S. to lift sanctions on its biggest shipping company, citing people familiar with the matter."InvestorPlace - Stock Market News, Stock Advice & Trading TipsGeopolitical negotiations are like any other negotiations: it's all about compromise and compromise is all about both sides feeling like they're benefiting. In other words, Trump probably won't get the all or nothing trade deal he wants and financial markets seem to be at peace with that.The Nasdaq Composite added 0.60% today, while the S&P 500 gained 0.64%. The Dow Jones Industrial Average climbed 0.57% with just over two-thirds of the index's 30 members higher in late trading. Caterpillar CallConstruction machinery maker Caterpillar (NYSE:CAT) was one of the Dow's top performers today, adding 2.7%, in a move that's likely attributable to the aforementioned traded news as Caterpillar is one of the more trade-sensitive names in the Dow. * 10 Winning Stocks to Buy and Stick With for the Long Haul Shares of Caterpillar have been in a funk recently, sliding more than 8% over the past month, a tumble that has turned the stock negative on the year, making it one of the worst performers in the Dow."Given new data that has come in and healthy skepticism to begin with, we reduced our estimates for the remainder of 2019 and for 2020 as the North American market weakened and further production cuts are probably necessary to align to retail demand," said William Blair analyst Larry De Maria, in a note out earlier this week in which the research pared 2019 and 2020 earnings estimates on Caterpillar.The company reports third-quarter results on Oct. 23. Another OffenderSpeaking of Dow Jones stocks that have seemingly not been able to get out of their own way this year, there's UnitedHealth (NYSE:UNH). Giving credit where it's due, the managed care provider traded higher today despite some bearish analyst commentary."Jefferies analyst David Windley is dampening any expectations for a turnaround. In a note out Thursday morning, Windley downgraded managed-care giant UnitedHealth Group to Hold from Buy, and cut price targets for six other stocks" in the managed care group, reports Josh Nathan-Kazis for Barron's. Better NewsApple (NASDAQ:AAPL) continues grinding higher. With Thursday's gain, the shares are up more than 6% this month. Today, yet another analyst chimed in on iPhone 11 demand and that boosted Apple stock."The market is clearly placing a higher value on AAPL's growth in sales of non-iPhone products, the expanding growth opportunity in services, and continued buyback activity," according to Longview Research. "With the iPhone now a tailwind for the first time in 18 months, we anticipate valuation can expand." To The CloudShares of Microsoft (NASDAQ:MSFT) notched modest gains today with Wall Street chiming on the company's surging cloud business, which has frequently been highlighted as an epic long-term catalyst for the stock. * 7 'A'-Rated Stocks to Buy for the Rest of 2019 Due in part to Azure, Microsoft's cloud unit, Wedbush analyst Daniel Ives is forecasting "a "solid beat across the board on both the top and bottom line as cloud strength on Azure and Office 365 continues to be the fuel in the tank" when the company posts quarterly results. Bottom Line on the Dow Jones TodayThe aforementioned U.S.-China trade confab is slated to last two days, so there are short odds that I'll be addressing that issue again tomorrow. Progress on that front was seemingly made today, leaving investors to hope for more of the same on Friday and that President Trump takes it easy on Twitter 24 hours.Love him or hate him, he's probably shrewd enough to realize he can spin any good news on trade with China into a political victory and that's something stocks are likely to respond to positively.As of this writing, Todd Shriber did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Super Boring Stocks to Buy With Super Safe Returns * 10 Winning Stocks to Buy and Stick With for the Long Haul * Don't Give Up on These 4 Cannabis Stocks The post Dow Jones Today: A Small U.S.-China Trade Deal Is Better Than Nothing appeared first on InvestorPlace.
UnitedHealth Group Inc. was downgraded by Jefferies analyst David Windley, citing concerns over competition from Anthem Inc. and and margins related to Medicare Advantage pricing. Windley cut his rating to hold from buy, and dropped his stock price target by 22% to $235 from $300. Windley's target is now the lowest among the 26 analysts surveyed by FactSet, making him the least bullish on the healthcare services company. Windley said Anthem's strategy to regain market share in the commercial group risk market "is showing traction," likely at UnitedHealth's expense. That suggests there is "more downside risk" to expectations when UnitedHealth management comments on the outlook for 2020. The company is scheduled to report third-quarter results on Oct. 15. UnitedHealth's stock edged up 0.1% in morning trading, while the Dow Jones Industrial Average rallied 157 points, or 0.6%. Windley also slashed his stock price targets on several other managed care organizations (MCOs), writing in a note to clients at that, "The primary poison in the punch bowl, political risk, won't likely abate for at least another 9 months."
The major stock indexes were squarely higher after President Trump's comments on U.S.-China trade talks. Apple stock was upgraded.
Jefferies analyst David Windley is dampening any expectations for a turnaround for managed-care stocks, as he downgraded managed-care giant UnitedHealth Group to Hold from Buy.
Millions of Americans now have access to on-demand telemedicine services 24/7 with the new UnitedHealthcare app. The UnitedHealthcare app provides health information for people on the go, offering plan participants a single source to help maintain and improve their well-being, access care and make the most of their health benefits.
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing more than 730 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of June […]
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Confidence and investment in artificial intelligence (AI) to improve health care remain high, according to a new survey of 500 U.S. health industry leaders from hospitals, health plans, life sciences and employers, on their attitudes and adoption of the technology. Significantly, compared with 2018 findings, this year’s results found a nearly 88% increase in the number of respondents who said their organizations have a strategy in place and have implemented AI. The second OptumIQ Annual Survey on AI in Health Care also reveals a shift in funding expectations for AI-related projects, as leaders estimate their organizations will invest an average of $39.7 million over the next five years – $7.3 million more than last year’s estimate.
DOW UPDATE The Dow Jones Industrial Average is climbing Monday morning with shares of UnitedHealth and Apple Inc. delivering strong returns for the blue-chip average. Shares of UnitedHealth (UNH) and Apple Inc.
President Trump's executive order with focus on Medicare Advantage will probably increase the participation of health insurers in the social benefit program.
UnitedHealth is a blue chip stock with a long history of providing excess returns. Yet, political news has inspired a rare selloff in the name, giving long-term investors a unique opportunity to buy shares into weakness.